MIT NEWDIGS Design Lab advances work on medical treatment financing strategies
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Bacteria with multicolor vision
Red, green, and blue light can be used to control gene expression in engineered E. coli.
MIT Corporation life member and biotech pioneer Henri Termeer dies at 71
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Using supplements? Order a personalized pill
Seed funding from the MIT Sandbox Innovation Fund helped Multiply Labs' founders launch their personalized dietary supplement startup.
New technology offers fast peptide synthesis
Automated manufacturing could make it easier to develop and test new peptide drugs.
3Q: Berhardt Trout on spurring innovation in drug manufacturing
From EpiPen pricing to government oversight, the making of medicine impacts all aspects of modern health care.
Compound potential
Kristala Jones Prather engineers microbes to produce compounds that can be used in industrial processes efficiently and economically.
MISTI: The global internship program
MIT International Science and Technology Initiatives (MISTI) matches MIT students to internships with corporate partners around the world.
How a new approach to funding Alzheimer’s research could pay off
Model indicates that diverse research approaches to the disease would be a rewarding investment.
The Internet of medical things
Stephen Miles helps to bring the benefits of serialized identification systems to translational medicine and research.
Biotech to the rescue
Ram Sasisekharan’s startups provide novel methods to fight disease and make better drugs.
Fast synthesis could boost drug development
Chemists devise a new way to manufacture peptide drugs, which hold promise for treating many diseases.
Conversations on sociotechnical systems
Seminar will focus on technological platforms for on-demand biopharmaceutical manufacturing